Patent · US Expired

Uses of recombinant colony stimulating factor-1

US5837229A · kind A · utility

8Cited by
13References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 11, 1995
Grant dateNov 17, 1998
Priority date
Expiry dateJan 11, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.